0000899243-19-016947.txt : 20190613
0000899243-19-016947.hdr.sgml : 20190613
20190613204947
ACCESSION NUMBER: 0000899243-19-016947
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190611
FILED AS OF DATE: 20190613
DATE AS OF CHANGE: 20190613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: High Katherine A
CENTRAL INDEX KEY: 0001631248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 19897452
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-11
0
0001674416
CRISPR Therapeutics AG
CRSP
0001631248
High Katherine A
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
43.52
2019-06-11
4
A
0
30000
0.00
A
2029-06-11
Common Stock
30000
30000
D
This option was granted on June 11, 2019 with respect to 30,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments.
/s/ Michael Esposito, attorney-in-fact
2019-06-13